Gujarat Themis Biosyn Ltd (GUJTHEM) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Gujarat Themis Biosyn Ltd on NSE and BSE, with an AI summary of each filing.
Please refer to the attachment
Others (Uncategorized) · 04 Nov 2026, 11:13 pm
Gujarat Themis Biosyn Issues Clarifications on Preferential Issue Gujarat Themis Biosyn released additional disclosures regarding its proposed preferential issue of up to 82,10,786 equity shares (face value ₹1 each) at ₹408 per share to secure in-principle stock exchange approval. The company clarified that the 12-month timeline for utilizing issue proceeds starts from the share allotment date. It also identified ultimate beneficial owners for proposed allottees: Special Situation India Fund (Srinath Narasimhan, Pankaj Kalra, Jigar Karania) and India Special Assets Fund III alongside ISAF III Onshore Fund (Amit Agarwal, Navin Sambtani, Kriti Ghosh).
Gujarat Themis Bioysn Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
Gujarat Themis Bioysn Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
Intimation of re-schedule of Investor & Analyst Meet.
Intimation · 16 Nov 2026, 4:00 pm
Gujarat Themis Biosyn Reschedules Q2 & H1 FY27 Investor Meet Gujarat Themis Biosyn Limited has rescheduled its physical Investor & Analyst Meet to discuss Q2 & H1 FY27 financial results. Originally scheduled for 5th Nov'26, the meeting will now take place on Monday, 16th Nov'26, from 4:00 PM onwards. The in-person group meet will be hosted at Sofitel, Bandra Kurla Complex, Mumbai.
Please refer to our Intimation of Investor & Analyst Meet scheduled on 5th November, 2026
Intimation · 28 Oct 2026, 2:08 am
Gujarat Themis Biosyn Schedules Investor Meet for Q2 & H1 FY27 Results Gujarat Themis Biosyn Limited will host a physical Investor & Analyst Meet on 5th Nov'26 at 4:00 PM IST onwards at Salon Pompadour, Sofitel, Bandra Kurla Complex, Mumbai. The company's management will discuss its financial performance for Q2 and H1 FY27 with the investor group.
Gujarat Themis Bioysn Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
To consider and approve the un-audited standalone and consolidated financial results for the period ended September 30, 2026
Intimation · 04 Nov 2026, 5:30 am
Gujarat Themis Bioysn Limited has informed the Exchange about Board Meeting to be held on 04-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 04 Nov 2026, 5:30 am
Gujarat Themis Biosyn Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and approve un-audited standalone ....
Intimation · 04 Nov 2026, 5:30 am
Gujarat Themis Biosyn Board Meeting Scheduled for 4th Nov'26 to Consider Q2 Results Gujarat Themis Biosyn Limited announced that its Board of Directors will meet on 4th Nov'26 to consider and approve the un-audited standalone and consolidated financial results, along with the Limited Review Reports, for the quarter and half-year ended 30th Sep'26. Additionally, pursuant to insider trading regulations, the trading window for designated persons has been closed from 1st Oct'26 and will remain closed until 48 hours following the publication of the financial results.
Please refer to our Scrutinizer Report and Voting Results of 45th Annual General Meeting counter signed by the Chairman.
Annual General Meeting · 02 Oct 2026, 12:49 am
Please refer to our counter signed Scrutinizer''s Report of 45th Annual General Meeting.
Annual General Meeting · 01 Oct 2026, 6:06 pm
Kindly refer to the attachment.
Annual General Meeting · 01 Oct 2026, 2:18 am
Gujarat Themis Biosyn 45th AGM Voting Results and Scrutinizer Report Gujarat Themis Biosyn announced the voting results of its 45th AGM held on 30th Sep'26. Shareholders approved eight out of nine resolutions with requisite majority, including the adoption of audited financial statements, dividend declaration, preferential equity issue to raise funds, and Articles of Association amendments (87.15% in favour). However, Resolution No. 7—an ordinary resolution seeking approval to avail loans and guarantees from promoters for acquisition and growth financing—was rejected after receiving 59.86% votes against from polled non-promoter shares (81.57% institutional votes against).
Please refer to our revised outcome of the Annual General Meeting due to typographical error.
Annual General Meeting · 01 Oct 2026, 1:37 am
Please refer to the Intimation of amendment to Articles of Association of the Company.
Others (Uncategorized) · 30 Sept 2026, 11:48 pm
Gujarat Themis Biosyn Approves Dividend, Preferential Issue, and AoA Amendment Members of Gujarat Themis Biosyn Limited approved a 67% dividend of Re. 0.67 per equity share (face value Re. 1/-), totaling Rs. 8,72,01,642/- for the financial year ended 31st Mar'26. Shareholders also approved raising capital via a preferential issue of equity shares alongside an amendment to Article 119 of the Articles of Association. The amendment permits financial institutions, lenders, and investors holding equity, debentures, or outstanding debt/guarantees to appoint a Board observer subject to transaction agreement terms.
Please refer to the outcome of 45th Annual General Meeting held on 30.09.2026
Annual General Meeting · 30 Sept 2026, 11:06 pm
Please refer to the attachment.
Annual General Meeting · 22 Sept 2026, 2:24 am
Gujarat Themis Biosyn Amends Preferential Issue to Raise Rs 335 Crore Gujarat Themis Biosyn issued an AGM notice corrigendum updating its preferential issue to up to 82,92,081 equity shares (FV Re 1) at Rs 404 per share, raising Rs 335.00 crore. Proceeds will fund the 100% equity acquisition of MicroBiopharm Japan Co., Ltd., including NCD redemption or debt repayment of Rs 310.00 crore, alongside Rs 25.00 crore for general corporate purposes within 12 months. Promoter entity Pharmaceutical Business Group (India) Limited will subscribe to 61,88,121 shares (Rs 250.00 crore), increasing total promoter holding from 59.33% to 60.25% post-issue.
Kindly refer to the attachment.
Dividend · 18 Sept 2026, 10:07 pm
Gujarat Themis Biosyn Sets Record Date For FY26 Final Dividend Gujarat Themis Biosyn Limited has fixed Wednesday, 23rd Sep'26, as the record date to determine shareholder entitlement for the final dividend for the financial year ended 31st Mar'26. The dividend payout remains subject to shareholder approval at the company's 56th Annual General Meeting scheduled for Wednesday, 30th Sep'26.
Please refer to the attachment.
Others (Uncategorized) · 18 Sept 2026, 4:01 pm
Gujarat Themis Biosyn Completes Acquisition of MicroBiopharm Japan for JPY 21.5 Billion Gujarat Themis Biosyn completed the 100% acquisition of MicroBiopharm Japan on 18th Sep'26 via its subsidiary, Themis Biosyn Japan, for JPY 21.5 billion, funded via INR 475 crore equity and an INR 745 crore loan. The transaction is expected to be EPS accretive. MBJ registered FY26 revenue of JPY 9.5 billion across proprietary APIs, CDMO, and biologics, with ~40% derived outside Japan across three GMP-compliant plants. The acquisition expands GTBL’s precision fermentation capabilities, novel modalities, and global CDMO reach.
Please refer to the Disclosure under Reg 30 of LODR.
Others (Uncategorized) · 17 Sept 2026, 12:53 am
Gujarat Themis Biosyn Raises INR 585 Crores via NCDs for Japan Acquisition Gujarat Themis Biosyn allotted secured, unlisted NCDs worth INR 585 Crores on private placement on 16th Sep'26. The proceeds will fund the acquisition of MicroBiopharm Japan Co., Ltd via its Japanese subsidiary and support general corporate purposes. The issue comprises Series 1 of INR 295 Crores (60-month tenure, 10% p.a. coupon) and Series 2 of INR 290 Crores (18-month tenure, 17.75% p.a. coupon). Both tranches feature monthly compounded interest paid quarterly starting from the 13th month and are backed by company assets and promoter guarantees.
Gujarat Themis Biosyn Limited has informed the Exchange regarding Outcome of Board Meeting held on September 10, 2026.
Outcome · 11 Sept 2026, 1:11 am
Please refer to the Outcome of the Board meeting held on 10.09.2026
Outcome · 11 Sept 2026, 1:07 am
Gujarat Themis Biosyn Approves INR 585 Crore NCD Issuance via Private Placement The Board of Directors of Gujarat Themis Biosyn Limited, at its meeting held on 10th Sep'26, approved the issuance of Non-Convertible Debentures (NCDs) aggregating up to INR 585 Crores on a private placement basis. The proposed NCDs will be unlisted. Key details, including tenure, coupon rates, payment schedules, and security/charges over assets, will be disclosed in due course at the time of allotment.
Please refer to the attachment
Annual General Meeting · 09 Sept 2026, 1:47 am
Gujarat Themis Biosyn Proposes AoA Amendment to Enable Board Observers and Flexible Financing Gujarat Themis Biosyn Limited issued an addendum to the notice of its 45th AGM scheduled for 30th Sep'26, seeking shareholder approval to amend Article 119 of its Articles of Association via special resolution. The amendment expands the definition of "Financial Institution" to encompass diverse investors, banks, funds, and lenders, removing statutory restrictions. Crucially, it empowers lenders and investing institutions holding debt, equity, or guarantees to appoint Board observers in addition to nominee directors, enhancing funding flexibility for corporate transactions.
Gujarat Themis Biosyn Limited has informed the Exchange about Board Meeting to be held on 10-Sep-2026 to consider Fund raising.
Intimation · 08 Sept 2026, 1:39 am
To consider Fund Raising
Intimation · 08 Sept 2026, 1:39 am
Gujarat Themis Biosyn Limited has informed the Exchange about Board Meeting to be held on 10-Sep-2026 to consider Fund raising.
Intimation · 08 Sept 2026, 1:34 am